BioSpace News Archive

Feb. 12, 2020 13:00 UTC -Dr. Scott C. Brun joins Axial Board to support the advancement of the Company’s Autism and Parkinson’s Programs- WALTHAM, Mass.--( BUSINESS WIRE )-- Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced the appointment of Scott Brun M.D. to its Board of Directors. In addition, the Company announced the promotions an

RCA Academy for Addiction and Behavioral Health Professionals to Provide Continuing Education Classes for Licensure and Certification by State Boards at No Cost to Practitioners

HealthMyne, a pioneering provider of integrated software solutions for radiomics-enabled clinical management, today announced that Carey Thomson, MD, MPH, Associate Professor, Harvard Medical School has joined the company’s growing Board of Clinical Advisors.

Capsule Technologies, a leading global provider of medical device integration, clinical surveillance, and patient monitoring for hospitals and healthcare organizations, announced today that their systems passed all required tests at the IHE North American Connectathon, which took place January 20 to 24 in Cleveland, Ohio.

Bruker Corporation (Nasdaq: BRKR) today announced that it is postponing its fourth quarter and full year 2019 earnings results call to allow additional time to complete its year-end closing procedures, including procedures related to the effective income tax rate for 2019 and the related income tax balance sheet accounts.

OLIGOMERIX., a privately held company pioneering the development of small molecule therapeutics targeting tau for Alzheimer’s disease (AD) and related neurodegenerative disorders, announced that the company presented efficacy data for its lead program, a small molecule inhibitor of tau self-association, in two preclinical models of tauopathy.

Feb. 12, 2020 13:07 UTC Compact, portable monitor that accurately measures patient’s resting energy expenditure to help optimize nutrition therapy Technology replaces potentially inaccurate predictive equations Expected to launch in the United States at ASPEN Conference in March 2020 DEERFIELD, Ill.--( BUSINESS WIRE )-- Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, today announced the U.S. Food and Drug Administration

MONTREAL, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today announced that it plans to host a conference call at 8:00 AM Eastern Time on Wednesday, February 19, 2020 to discuss the Company’s financial results for the third quarter ended December 31, 2019, as well as the Company’s corporate progress and other developments. The Company expects to file its financial statements along with its MD&A post market on Febru

Total Revenue for 2019 increases 18.7% to $3.5 million, up from $3.0 million in 2018 Curetis - OpGen business combination shareholder votes set for March 10, 2020 GAITHERSBURG, Md., Feb. 12, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that total revenue for 2019 increased 18.7% to $3.5 million, up from $3.0 million in 2018. The com

SYDNEY , Feb. 12, 2020 /PRNewswire/ -- George Clinical, a global scientifically-backed clinical research organization, has named James Cheong to the role of Chief Executive Officer. Cheong was hired as Chief Operating Officer at the beginning of 2019 and has overseen substantial growth of the business, leadership team and international footprint. Cheong succeeds Glenn Kerk